Bank of America’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
VCM
EAM
BGM
KCM
Bank of America's TNYA Position: Q1 2026 in Review
Bank of America reduced its Tenaya Therapeutics (TNYA) stake by 9.3% in Q1 2026, selling an estimated $2.21K and leaving 29,083 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5654.
Bank of America first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.18M in Q1 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.
- Bank of America held 29,083 shares of Tenaya Therapeutics worth $20.1K as of Q1 2026.
- Bank of America sold 2,992 Tenaya Therapeutics shares in Q1 2026, an estimated $2.21K.
- Tenaya Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5654 holding.
- Bank of America first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
- Bank of America's Tenaya Therapeutics position peaked at $1.18M in Q1 2024.
- 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.